UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, ~~D.C.~~DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the ~~Securities Exchange Act of 1934~~

~~Date of~~Securities ~~Report:~~Exchange ~~October~~Act ~~23,~~of ~~2009~~1934

Date of ~~Earliest~~Report ~~Event~~(Date ~~Reported:~~of ~~October~~earliest 19event reported): November 4, 2009

Medis Technologies Ltd. ~~(Exact name of registrant as specified in its charter)~~

Delaware	0-30391	13-3669062
(State or other jurisdiction	(Commission	(I.R.S. Employer
of incorporation)	File Number)	Identification No.)
805 Third Avenue, New York, NY		10022
(Address of principal executive offices)		(Zip Code)

(Exact name of Registrant as specified in its charter)

~~Registrant’s telephone~~Delaware ~~number,~~(State ~~including~~of ~~area~~incorporation) ~~code:~~0-30391 (~~212~~Commission File No.) ~~935~~ 13-~~8484~~3669062 (IRS Employer Identification No.)

~~(Former~~805 Third ~~name or former address, if changed since last report)~~Avenue

~~Check the~~New ~~appropriate~~York, ~~box~~New ~~below~~York ~~if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:~~10022

~~[_] Written communications pursuant to Rule 425 under the Securities Act~~ (17Address of ~~CFR~~principal ~~230.425)~~executive ~~[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12~~offices) [_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Item~~Registrant’s ~~2.03.~~telephone number: ~~Creation~~(212) ~~of a Direct Financial Obligation or an Obligation under an Off~~935-~~Balance Sheet Arrangement of a Registrant~~8484

~~Effective as~~Check ~~of October 19, 2009, Medis Technologies Ltd. (“Medis”) assumed approximately $4,417,908 of outstanding trade debt (~~the ~~“Claims”)~~appropriate ofbox ~~its~~below ~~wholly~~if ~~owned subsidiary, More Energy Ltd.~~the ~~(“More”). The~~Form ~~debt~~8-K ~~was~~filing ~~initially~~is ~~incurred~~intended byto ~~More~~simultaneously insatisfy the ~~ordinary course~~filing ofobligation ~~its business and subsequently acquired by American Capital Management,~~of ~~LLC (~~the ~~“Claim~~Registrant ~~Holder”).~~under Onany orof ~~around October 20, 2009,~~ the ~~Claim~~following ~~Holder sued Medis in Los Angeles Superior Court for repayment of the Claims.~~provisions:

~~Forward-Looking~~o Written ~~Statements~~communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

~~This~~o Soliciting ~~Current~~material ~~Report~~pursuant ~~on Form 8-K contains forward-looking statements. Investors are cautioned that forward-looking statements inherently involve risks and uncertainties that could cause actual results~~ to ~~differ~~ ~~materially~~Rule ~~from those contemplated in the forward~~14a-~~looking statements. Such~~12 ~~risks~~under ~~include, but are not limited to,~~ the ~~risks~~Exchange ~~and uncertainties~~Act ~~outlined~~(17 ~~in Medis’s documents filed with the SEC. All~~CFR ~~forward-looking statements and other information in this Current Report on Form 8-K are based upon information available as of the date of this Report~~240. ~~Such information may change or become invalid after the date of this Current Report, and, by making these forward~~14a-~~looking statements, Medis undertakes no obligation to update these statements after the date of this Current Report, except as required by law.~~12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events.

On November 4, 2009, current and former employees of Medis El Ltd. (“Medis El”) and More Energy Ltd. (“More”), each a wholly owned subsidiary of Medis Technologies Ltd. (“Medis”), commenced liquidation actions with respect to each of Medis El and More in court in Israel. Medis intends to cooperate in these proceedings to facilitate an orderly liquidation of each of Medis El and More. Medis expects a liquidator for Medis El and More to be appointed by the Israeli courts.

Item 9.01. Financial Statements and Exhibits.

(a)	Financial Statements of Businesses Acquired - None

(b)	Pro Forma Financial Information - None

(c)	Shell Company Transactions - None

(d)

Exhibits:

Exhibit No.		Description

99.1		Press Release dated November 4, 2009

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the ~~registrant~~Registrant has duly caused this ~~Report~~report to be signed on its behalf by the undersigned, hereunto duly authorized.

	Medis Technologies Ltd.
Date: October 23, 2009	By:	/s/ Steven N. Crea
		Steven N. Crea
		Chief Financial Officer

Dated: November 4, 2009

	MEDIS TECHNOLOGIES LTD.

	By:	/s/ Jose Mejia
		Name: Jose Mejia
		Title: Chief Executive Officer

Filing Compare · MEDIS TECHNOLOGIES LTD